Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neptune II: Long-term Solifenacin + Tamsulosin for LUTS/BPH
NCT01021332Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2010
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of solifenacin, tamsulosin in benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), sponsored by Astellas Pharma. Started Apr 2010; status: completed.
02
Drugs
solifenacintamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT01021332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01021332.